Osteoarthrosis or osteoarthritis? The name of the disease through the eyes of a practitioner
https://doi.org/10.14412/2074-2711-2010-124
Abstract
The paper presents data on the clinical presentation and pathogenesis of osteoarthrosis (OA), the basis for which is both articular tissue inflammation and degeneration. It provides the ultrasonographic characteristics of synovitis in OA. The author describes anti-inflammatory therapy for knee OA in an exacerbation phase, by using amelotex, a nonsteroidal anti-inflammatory drug with selective inhibition of COX-2, and positive therapeutic results as reduced joint pain and swelling, increased volume of movements, and its good tolerability.
About the Author
N. A. Khitrov
Training-Research Medical Center, Department for Presidential Affairs of the Russian Federation
Russian Federation
Moscow
Russian Federation
Moscow
References
1. <div><p>Ревматические болезни. Рук-во для врачей. Под ред. В.А. Насоновой, Н.В. Бунчука. М.: Медицина, 1997;385-96.</p><p>Raisz L.G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthr Cartilage 1999;79:83-94.</p><p>Laufer S., Gay S., Brune K. Inflammation and Rheumatic Diseases: The molecular basis of novel therapies. Georg Thieme Verlag, 2003;139 p.</p><p>Grushko G., Schneiderman R., Maroudas A. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of aging and degeneration in human hip cartilage. Connec Tissue Res 1989;19:149-76.</p><p>Ревматология: национальное руководство. Под ред. Е.Л. Насонова, В.А. Насоновой. М.: ГЭОТАР-Медиа, 2008;573-88.</p><p>Hedbom E., Huselmann H.J. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002;59:45-53.</p><p>Pickvance E.A., Oegema T.R.Jr., Thompson R.C. Immunolocalization of selected cytokines and proteases in canine articular cartilage after transarticular loading. J Orthop Res 1993;113:313-23.</p><p>Agarwal S., Long P., Seyedain A. et al. A central role for the nuclear factor-kB pathway in anti-inflammatory and proinflammatory actions of mechanical strain. FASEB J 2003;17:899-901.</p><p>Насонов Е.Л., Каратеев А.Е. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. РМЖ 2006;14(25):1769-77.</p><p>Feldman M., McMahon A.T. Do cyclooxigenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 2000;132:134-43.</p><p>Цветкова Е.С., Панасюк Е.Ю., Иониченок Н.Г. и др. Перспективы применения ингибиторов циклооксигеназы-2 при остеоартрозе. Consilium medicum 2004;6(2):100.</p><p>Каратеев А.Е., Барскова В.Г. Критерии выбора нестероидного противовоспалительного препарата. Справочник практического врача 2007;5(5):13-7.</p><p>Hawkey C., Kahan A., Steinbruck К. Gastrointestinal tolerability of meloxicam compared to diclofenac in patients. International MELISSA Study Group. Meloxicam Largescale International Study Safety Assessment. Br J Rheumatol 1998;37(9):937-45.</p><p>Valat J.P., Accardo S., Reginster J.Y. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine. Inflamm Res 2001;50(Suppl. 1):30-4.</p><p>Tavakoli M. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam. Pharmacoeconom 2003;21(6):443-54.</p></div><br />
Review
For citations:
Khitrov N.A. Osteoarthrosis or osteoarthritis? The name of the disease through the eyes of a practitioner. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):85-90. (In Russ.) https://doi.org/10.14412/2074-2711-2010-124
Views: 927
Email this article 